2014
DOI: 10.1016/j.bioorg.2013.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Mycothiol: A promising antitubercular target

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 59 publications
0
10
0
Order By: Relevance
“…tuberculosis (Table S3) and could represent possible future drug-targets. This would be particularly attractive in combination with inhibitors of MSH biosynthesis to combat tuberculosis (TB) disease since MshB inhibitors are successfully applied in the clinical practice 54, 55 .…”
Section: Discussionmentioning
confidence: 99%
“…tuberculosis (Table S3) and could represent possible future drug-targets. This would be particularly attractive in combination with inhibitors of MSH biosynthesis to combat tuberculosis (TB) disease since MshB inhibitors are successfully applied in the clinical practice 54, 55 .…”
Section: Discussionmentioning
confidence: 99%
“…Thus, inhibitors of MSH biosynthesis enzymes are promising candidates for antituberculosis drug developments. Several MSH biosynthesis inhibitors have been applied that target the MSH- S -conjugate amidase Mca, the deacetylase MshB, the cysteine ligase MshC and the MSSM reductase Mtr that are attractive antituberculosis drug targets (Nilewar and Kathiravan, 2014 ).…”
Section: Biosynthesis and Functions Of Major Lmw Thiol-redox Buffers mentioning
confidence: 99%
“…In conjunction with mycothiol (MSH), MCA plays an analogous role to glutathione in eukaryotes in protecting the cell against oxidative stress by covalently binding to alkylating agents, electrophiles, and drugs to form mycothiol‐ S ‐conjugates . Therefore, it is essential for growth and survival of M. tuberculosis . MCA shares no sequence homology to other known eukaryotic enzymes and, hence, drugs inhibiting MCA homologs represent a novel and attractive target for new classes of antimycobacterials .…”
Section: Marine Invertebrate Compounds With Anti‐tb Activitymentioning
confidence: 99%
“…Therefore, it is essential for growth and survival of M. tuberculosis . MCA shares no sequence homology to other known eukaryotic enzymes and, hence, drugs inhibiting MCA homologs represent a novel and attractive target for new classes of antimycobacterials . It is assumed that the spiro‐isoxazoline and oximino amide groups of 49 and 50 , respectively, mimic conformations of mycothiol‐ S ‐conjugates, and therefore, act as substrate mimics .…”
Section: Marine Invertebrate Compounds With Anti‐tb Activitymentioning
confidence: 99%